A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan

Globally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors assoc...

Full description

Bibliographic Details
Main Authors: Madoka Lelliott, Ethan Sahker, Hemant Poudyal
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/12/5/2004
_version_ 1797615018928242688
author Madoka Lelliott
Ethan Sahker
Hemant Poudyal
author_facet Madoka Lelliott
Ethan Sahker
Hemant Poudyal
author_sort Madoka Lelliott
collection DOAJ
description Globally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors associated with HPV vaccine uptake and potential strategies to reduce vaccine hesitancy among Japanese parents. Articles published in English or Japanese between January 1998 and October 2022 that examined Japanese parental factors for HPV vaccine uptake were identified from PubMed, Web of Science, and Ichushi-Web. In total, 17 articles met the inclusion criteria. Four key themes which affected HPV vaccine hesitancy and acceptance were identified: perceptions of risk and benefits, trust and recommendation, information and knowledge, and sociodemographic characteristics. While governmental and healthcare provider recommendations are important factors, efforts to improve parental confidence in the HPV vaccine are required. Future interventions to counteract HPV vaccine hesitancy should actively disseminate information on vaccine safety and effectiveness, along with information on the severity and susceptibility of HPV infection.
first_indexed 2024-03-11T07:20:32Z
format Article
id doaj.art-5c353fc7356347f8a2aa1abb504ed4e2
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-11T07:20:32Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-5c353fc7356347f8a2aa1abb504ed4e22023-11-17T08:01:18ZengMDPI AGJournal of Clinical Medicine2077-03832023-03-01125200410.3390/jcm12052004A Review of Parental Vaccine Hesitancy for Human Papillomavirus in JapanMadoka Lelliott0Ethan Sahker1Hemant Poudyal2Department of Health Promotion and Human Behavior, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto 606-8501, JapanDepartment of Health Promotion and Human Behavior, Graduate School of Medicine/School of Public Health, Kyoto University, Kyoto 606-8501, JapanPopulation Health and Policy Research Unit, Graduate School of Medicine, Kyoto University, Kyoto 606-8501, JapanGlobally, Japan has the lowest rate of vaccine confidence. The persistent parental vaccine hesitancy has been attributed to safety and efficacy concerns and is primarily driven by the negative experience with human papillomavirus (HPV) vaccines. This literature review aimed to identify factors associated with HPV vaccine uptake and potential strategies to reduce vaccine hesitancy among Japanese parents. Articles published in English or Japanese between January 1998 and October 2022 that examined Japanese parental factors for HPV vaccine uptake were identified from PubMed, Web of Science, and Ichushi-Web. In total, 17 articles met the inclusion criteria. Four key themes which affected HPV vaccine hesitancy and acceptance were identified: perceptions of risk and benefits, trust and recommendation, information and knowledge, and sociodemographic characteristics. While governmental and healthcare provider recommendations are important factors, efforts to improve parental confidence in the HPV vaccine are required. Future interventions to counteract HPV vaccine hesitancy should actively disseminate information on vaccine safety and effectiveness, along with information on the severity and susceptibility of HPV infection.https://www.mdpi.com/2077-0383/12/5/2004immunizationchildrenparentscervical cancervirus
spellingShingle Madoka Lelliott
Ethan Sahker
Hemant Poudyal
A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
Journal of Clinical Medicine
immunization
children
parents
cervical cancer
virus
title A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
title_full A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
title_fullStr A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
title_full_unstemmed A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
title_short A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan
title_sort review of parental vaccine hesitancy for human papillomavirus in japan
topic immunization
children
parents
cervical cancer
virus
url https://www.mdpi.com/2077-0383/12/5/2004
work_keys_str_mv AT madokalelliott areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan
AT ethansahker areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan
AT hemantpoudyal areviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan
AT madokalelliott reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan
AT ethansahker reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan
AT hemantpoudyal reviewofparentalvaccinehesitancyforhumanpapillomavirusinjapan